Clinical Trial Update: Liposomal Bupivacaine for Pain Control Following Thoracic Surgery. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating liposomal bupivacaine for controlling postoperative pain after thoracic surgery; status details are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pain, Postoperative, Thoracic Diseases | Phase 2, Phase 3 | Status: UNKNOWN